ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The expression and clinical significance of TPM4 in hepatocellular carcinoma

Li, Linjing*; Ye, Tao; Zhang, Qingyan; Li, Xin; Ma, Li; Yan, Jing南方医科大学; 兰州大学; 中山大学; 1
International Journal of Medical Sciences2021DOI: 10.7150/ijms.49906
11被引6阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is known as the fifth most common cancer in the world for its poor prognosis. New diagnostic markers and treatments are urgent to discover. To evaluate the protein expression of Tropomyosin4 (TPM4) and investigate its prognostic value in HCC, we collected 110 patients with different degrees of HCC and 10 patients with normal hepatic tissues and performed immunohistochemistry. Western bot was used to evaluate the expression of TPM4 in three HCC cell lines (HepG2, Huh7, SMMC-7721) and normal liver cell line LO2, as well as 7 HCC tissues and 7 normal hepatic tissues. The results of TPM4 staining revealed that TPM4 expression in HCC was higher than that in normal hepatic tissues, which was positive in 51.8% (n=57) and negative in 48.2% (n=53) while in normal hepatic tissues positive staining was in 10% (n=1) and negative staining was in 90% (n=9) (P=0.011). And the expression of TPM4 was related to pT status, grade and stage (P<0.001, P=0.015 and P<0.001, respectively). Western blot results indicated that TPM4 was high expressed in HCC cell line and HCC tissues. In conclusion, we believe that TPM4 can be applied as a diagnostic and prognostic marker to assist the management of HCC.

学科与关键词

关键词
hepatocellular carcinomaTPM4biological markerclirticopathological parametersdiagnosis
相关
加载中…
  • Increased expression of MCM4 is associated with poor prognosis in patients with hepatocellular carcinoma
    Zheng, Ruinian; Lai, Guowei; Li, Rongfa; Hao, Yanyan; Cai, Limin*; Jia, Jun*Journal of Gastrointestinal Oncology, 2021, 12(1): 153-173.被引 7
  • MACC1 as a Prognostic Biomarker for Early-Stage and AFP-Normal Hepatocellular Carcinoma
    Xie Chan; Wu Jueheng; Yun Jingping; Lai Jiaming; Yuan Yunfei; Gao Zhiliang; Li Mengfeng; Li Jun; Song Libing*PLoS ONE, 2013, 8(5): e64235.被引 17
  • EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma
    Li, Linjing*; Li, Xin; Zhang, Qingyan; Ye, Tao; Zou, Shuli; Yan, JingAmerican Journal of Cancer Research, 2021, 12(16): 4774-4779.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Medical Sciences
发表日期
2021
卷期
第 18 卷, 第 1 期
页码
169-175
DOI
10.7150/ijms.49906
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82060531]; Internationally Technological Cooperation Project of Gansu Province [18YF1WA117]; Longyuan Youth Creative and Innovative talents Project of Gansu Province [2020RCXM149]; Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital [CY2018-MS11]; Science and Technology Development Guidance Project of Lanzhou city [2019-ZD-68]

作者

  • L

    Li, Linjing (通讯) (第一作者)

    2 · lanzhou univ

  • Y

    Ye, Tao

    1 · southern med univ

查看全部 6 位作者收起作者
  • Z

    Zhang, Qingyan

    1 · sun yat sen univ

  • L

    Li, Xin

    1 · southern med univ

  • M

    Ma, Li

    2 · lanzhou univ

  • Y

    Yan, Jing

    2 · lanzhou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417